Please login to the form below

Not currently logged in
Email:
Password:

real-world study

This page shows the latest real-world study news and features for those working in and with pharma, biotech and healthcare.

FDA starts review of Biogen’s Tecfidera follow-up for MS

FDA starts review of Biogen’s Tecfidera follow-up for MS

The US filing for Vumerity is a truncated package based on the EVOLVE-MS-1 study which showed it was bioequivalent to Tecfidera, along with pharmacokinetic bridging studies comparing the two ... Some also say that the side effects with Tecfidera are

Latest news

  • Biogen files Tecfidera follow-up in the US Biogen files Tecfidera follow-up in the US

    Biogen is also enrolling patients a head-to-head tolerability study versus Tecfidera with data due in mid-2019. ... However, a recent ‘real-world’ study conducted in Sweden found that a majority of Tecfidera patients at one clinic – around 57% –

  • J&J’s Invokana aces diabetic kidney disease trial, setting up filings J&J’s Invokana aces diabetic kidney disease trial, setting up filings

    Johnson &Johnson’s SGLT2 inhibitor Invokana worked so well in a trial involving diabetics with chronic kidney disease that the study has been halted early – potentially opening up a lucrative new ... dapagliflozin). Since then J&J has been trying to

  • J&J says real-world data finds no amputation risk for Invokana J&J says real-world data finds no amputation risk for Invokana

    The study depicts how patients are faring on these drugs in the real-world, according to investigator John Buse of the University of North Carolina School of Medicine, who said the ... AZ is still waiting for data read-outs from its cardiovascular

  • Real-world data finds patients feel better on Entresto, says Novartis Real-world data finds patients feel better on Entresto, says Novartis

    The real-world data - reported at the European Society of Cardiology Heart Failure (ESC-HF) Congress over the weekend - comes from the CHAMP-HF registry of heart failure patients and specifically ... The real-world evidence adds to hard clinical

  • Amgen signs real world study and mobile data partnership Amgen signs real world study and mobile data partnership

    Initially targeting multiple conditions, including cardiovascular disease, osteoporosis, neurologic disorders, inflammatory diseases and cancer, researchers will combine real world evidence with data from wearable technology, digital apps and

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    data. The importance of real-world data is growing rapidly, but its quality, taxonomy and accessibility are not standardised and once again require collaboration to pull it off. ... An example is the real-world observational study GSK conducted for its

  • The gold standard of scientific evidence The gold standard of scientific evidence

    However, randomisation can be incorporated into real-world study designs. For instance, pragmatic trial designs blend randomisation with real-world treatment practices. ... For starters, researchers should make available study protocols for all research

  • Pulling together Pulling together

    The real world and data. One aspect of the UK that both the government and industry are keen to talk up is its health service and the opportunity of working with ... Launched in 2012 it was the first time a large, prospective real-world study was

  • Interview: Deepak Khanna, ABPI Interview: Deepak Khanna, ABPI

    Referencing a 'real-world' study into GlaxoSmithKline's (GSK) Relovair in Salford, he says: “We have a good example where the NHS partnered with three companies to focus on COPD.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Webinar: Demand assessment - Reflecting real world choices

    How study design which reflects doctors’ real world choices can optimise results. ... study design which reflects doctors’ real world choices can optimise results. .

  • Research Partnership

    Therapy Watch recently presented “real-world” patient data on treatment duration and persistence among European PsO patients. ... How study design which reflects doctors’ real world choices can optimise results.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics